한글목차

재생의료 시장은 2025년에 1,252억 5,000만 달러로 추정되며, 2032년까지 3,476억 3,000만 달러에 달할 것으로 예측됩니다. 2025-2032년 CAGR 15.7%로 성장할 것으로 전망되고 있습니다.

재생의료는 줄기세포를 이용한 치료법으로 의학 분야에서 가장 빠르게 발전하고 있는 분야 중 하나입니다. 노화나 손상으로 인해 정상적인 기능을 유지하는 데 필요한 최적의 양의 줄기세포 공급이 어려워집니다. 재생의료의 목적은 이 자연치유 시스템을 증폭시켜 환자의 요구에 부응하는 것입니다. 정형외과는 재생의료의 한 분야로 근골격계 세포의 재생을 자극하여 자연 치유 과정을 활용합니다. 히스토젠은 정형외과용 재생의료 제품 제조업체 중 하나로, 자사 제품인 인간 세포외기질(hECM)은 항염증 작용과 혈관신생 작용을 가지고 있으며, 손상 부위에서 줄기세포의 성장을 가속하여 조직 재생을 유도합니다.

시장 역학

손상된 조직과 장기를 복구하고 재생하는 혁신적인 치료법에 대한 수요가 증가함에 따라 재생의료 시장은 빠르게 성장하고 있습니다. 시장 역학은 줄기세포 치료, 조직공학, 유전자 치료의 발전에 의해 형성되고 있으며, 이는 시장 성장을 주도하고 있습니다. 비용과 규제상의 복잡성 등 어려움이 있지만, 지속적인 기술 발전과 연구개발에 대한 투자 확대가 시장을 발전시키고 있습니다. 인지도가 높아지고 임상적 근거가 축적됨에 따라 재생의료 시장은 혁신적인 솔루션을 제공하고 환자 치료 결과를 개선함으로써 의료를 변화시킬 수 있는 잠재력을 가지고 있습니다.

세계 재생의료 시장의 제약 요인

조직공학 및 생체의료공학에 대한 표준화된 가이드라인의 부족은 세계 재생의료 시장의 성장을 저해할 것으로 예측됩니다. 또한 임상시험의 장기화로 인한 제품 출시 지연도 시장 성장을 저해하는 요인으로 작용할 것으로 보입니다.

이 보고서의 주요 특징

• 세계의 재생의료 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측기간(2025-2032년) 시장 규모와 CAGR을 조사하여 전해드립니다.
• 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트을 제공합니다.
• 세계 재생의료 시장의 주요 기업 개요을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 주요 매개 변수에 따라 정리하여 수록했습니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• '세계 재생의료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 재생의료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장 정의와 범위
• 개요
• Coherent Opportunity Map(COM)

제3장 시장 역학·규제·동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 기회
• 영향 분석
• 주요 발전
• 규제 환경
• PEST 분석

제4장 세계의 재생의료 시장 : 조직 유형별(2020-2032년)

• 동종 이식
• 이종 이식
• 인공 조직

제5장 세계의 재생의료 시장 : 용도별(2020-2032년)

• 연조직 수복
• 심혈관
• 치과
• 정형외과
• 중추신경계 질환 치료
• 기타

제6장 세계의 재생의료 시장 : 최종사용자별(2020-2032년)

• 병원
• 외래 수술 센터
• 교육 기관

제7장 세계의 재생의료 시장 : 지역별(2020-2032년)

• 북미
• 미국
• 캐나다
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• ASEAN
• 호주
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 중동
• GCC
• 이스라엘
• 기타 중동
• 아프리카
• 북아프리카
• 중앙아프리카
• 남아프리카

제8장 경쟁 구도

• 기업 개요
  • Shire Pharmaceuticals
  • Kinetic Concepts, Inc.
  • Mesoblast Ltd.
  • Metcela Inc.
  • Nuo Therapeutics(Cytomedix Inc.)
  • Integra LifeSciences
  • Advanced Cell Technology, Inc.
  • BioStem Life Sciences
  • Akron Biotechnology, LLC
  • Organovo Holdings Inc.
  • Orgenesis Inc.
  • Pluristem Therapeutics Inc.
  • Genzyme
  • Athersys, Inc.
  • RenovaCare, Inc.
  • Cytori Therapeutics, Inc.

제9장 섹션

• 참고 문헌
• 분석 방법

영문목차

Regenerative Therapies Market is estimated to be valued at USD 125.25 Bn in 2025 and is expected to reach USD 347.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.7% from 2025 to 2032.

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Market Dynamics

The regenerative therapy market is witnessing rapid expansion due to the increasing demand for innovative treatments that can restore and regenerate damaged tissues and organs. Market dynamics are being shaped by advancements in stem cell therapies, tissue engineering, and gene therapy, which are driving the market's growth. Despite challenges related to cost and regulatory complexities, continuous technological advancements and growing investments in research and development are driving the market forward. As awareness grows and clinical evidence accumulates, the regenerative therapy market is poised to transform healthcare by offering transformative solutions and improving patient outcomes.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study

• This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Metcela Inc., Nuo Therapeutics (Cytomedix Inc.), Integra LifeSciences, Advanced Cell Technology Inc., BioStem Life Sciences,Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., Cytori Therapeutics, Inc.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

• Global Regenerative Therapies Market, By Tissue Type
  • Allograft
  • Xenograft
  • Alloplast
• Global Regenerative Therapies Market, By Application
  • Soft Tissue Repair
  • Cardiovascular
  • Dental
  • Orthopedic
  • CNS disease treatment
  • Others
• Global Regenerative Therapies Market, By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Educational Institutes
• Global Regenerative Therapies Market, By Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Central Africa
  • South Africa
  • North Africa
• Company Profiles
  • Shire Pharmaceuticals
  • Kinetic Concepts, Inc.
  • Mesoblast Ltd.
  • Metcela Inc.
  • Nuo Therapeutics (Cytomedix Inc.)
  • Integra LifeSciences
  • Advanced Cell Technology, Inc.
  • BioStem Life Sciences
  • Akron Biotechnology, LLC
  • Organovo Holdings Inc.
  • Orgenesis Inc.
  • Pluristem Therapeutics Inc.
  • Genzyme
  • Athersys, Inc.
  • RenovaCare, Inc.
  • Cytori Therapeutics, Inc.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Tissue Type
  • Market Snippet, By Application
  • Market Snippet, By End User
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Developments
• Regulatory Scenario
• PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2020-2032(US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032(%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Allograft
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Xenograft
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends
• Alloplast
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
  • Segment Trends

5. Global Regenerative Therapies Market, By Application, 2020-2032(US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032(%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Soft Tissue Repair
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• CNS disease treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

6. Global Regenerative Therapies Market, By End User, 2020-2032(US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032(%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Educational Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Regenerative Therapies Market, By Regions, 2020-2032(US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032(%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Company Profiles
  • Shire Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Kinetic Concepts, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mesoblast Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Metcela Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nuo Therapeutics (Cytomedix Inc.)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integra LifeSciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Advanced Cell Technology, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioStem Life Sciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akron Biotechnology, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organovo Holdings Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Orgenesis Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pluristem Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genzyme
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Athersys, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • RenovaCare, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cytori Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact